Labetalol Plus Magnesium Sulfate Lowers Intraoperative BP Variability in HDP Cesarean
This retrospective cohort suggests adding intravenous magnesium sulfate to oral labetalol stabilizes intraoperative blood pressure and improves early neonatal outcomes in hypertensive disorders of pregnancy undergoing cesarean delivery.
📅 Journal publication: Aug 13, 2026·Last updated: Aug 18, 2026
labetalolmagnesium sulfatehypertensive disorders of pregnancypreeclampsiacesarean deliveryblood pressure variabilitybeta-blockerobstetric pharmacologyretrospective cohortpropensity score matchingWomen's Health / Reproductive
Labetalol and magnesium sulfate stabilize blood pressure in cesarean deliveries.
Managing blood pressure during cesarean delivery in patients with hypertensive disorders of pregnancy is crucial for maternal and neonatal safety. The combination of labetalol and magnesium sulfate significantly reduced intraoperative systolic blood pressure variability and improved neonatal Apgar scores compared to labetalol alone. This study supports using labetalol with magnesium sulfate to achieve more stable intraoperative blood pressure and better neonatal outcomes in hypertensive pregnancies. Labetalol with magnesium sulfate offers superior intraoperative blood pressure control and neonatal outcomes in cesarean deliveries for hypertensive pregnancies.
📊 Deep Analysis Available
Subscribers get the full breakdown: study design, outcomes, pharmacist implications, clinical pearls, GRADE evidence grade, and a downloadable PDF report. Cancel anytime.
Free account, no credit card. Includes 1 full deep analysis every month.
Authors:Gao C, Lv J
Citation:Gao C, Lv J Comparison of Labetalol With Versus Without Magnesium Sulfate on Intraoperative Blood Pressure Variability During Cesarean Delivery in Hypertensive Disorders of Pregnancy: A Retrospective Cohort Study. Annali italiani di chirurgia. 2026;97(8):1471-1479. doi:10.62713/aic.4542